Serum uric acid levels correlate with recurrence of paroxysmal atrial fibrillation after catheter ablation

Chinese Medical Journal

Volumn 126, Issue 5, 2013, Pages 860-864

  He, Xiao nan ^a,b   Li, Song nan ^a   Zhan, Jin liang ^c   Xie, Shuang lun ^d   Zhang, Zhi jun ^a   Dong, Jian zeng ^a   Yu, Rong hui ^a   Long, De yong ^a   Tang, Ri Bo ^a   Ma, Chang Sheng ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b TIANJIN CHEST HOSPITAL   (China)

^c BEIJING INSTITUTE OF TECHNOLOGY   (China)

^d SUN YAT SEN MEMORIAL HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Atrial fibrillation; Catheter ablation; Recurrence; Uric acid

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CATHETER ABLATION; DISEASE ASSOCIATION; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGY; FEMALE; FIBRINOGEN BLOOD LEVEL; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HUMAN; HYPERTENSION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PULMONARY VEIN ISOLATION; RECURRENT DISEASE; RETROSPECTIVE STUDY; SUPRAVENTRICULAR TACHYCARDIA; URIC ACID BLOOD LEVEL;

AGED; ATRIAL FIBRILLATION; CATHETER ABLATION; ELECTROPHYSIOLOGY; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; URIC ACID;

EID: 84875328399     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20122154     Document Type: Article

References (30)

1. Lo B, Fijnheer R, Nierich AP, Bruins P, Kalkman CJ. C-reactive protein is a risk indicator for atrial fibrillation after myocardial revascularization. Ann Thorac Surg 2005; 79: 1530-1535.
2. Miao CL, Yin XD, Dong JZ, Liu XP, Yu RH, Long DY, et al. Catheter ablation of persistent atrial fibrillation with and without a history of paroxysmal atrial fibrillation. Chin Med J 2012; 125: 1175-1178.
3. Ng CY, Liu T, Shehata M, Stevens S, Chugh SS, Wang X. Meta-analysis of obstructive sleep apnea as predictor of atrial fibrillation recurrence after catheter ablation. Am J Cardiol 2011; 108: 47-51.
4. den Uijl DW, Gawrysiak M, Tops LF, Trines SA, Zeppenfeld K, Schalij MJ, et al. Prognostic value of total atrial conduction time estimated with tissue doppler imaging to predict the recurrence of atrial fibrillation after radiofrequency catheter ablation. Europace 2011; 13: 1533-1540.
5. Wang P, Dong JZ, Long DY, Ning M, Tang RB, Yu RH, et al. Impact of different termination modes on atrial fibrillation termination in catheter ablation of persistent atrial fibrillation. Chin Med J 2012; 125: 1877-1883.
6. Suzuki S, Sagara K, Otsuka T, Matsuno S, Funada R, Uejima T, et al. Gender-specific relationship between serum uric acid level and atrial fibrillation prevalence. Circ J 2012; 76: 607-611.
7. Liu X, Dong J, Mavrakis HE, Hu F, Long D, Fang D, et al. Achievement of pulmonary vein isolation in patients undergoing circumferential pulmonary vein ablation: A randomized comparison between two different isolation approaches. J Cardiovascular Electrophysiol 2006; 17: 1263-1270.
8. Tang RB, Dong JZ, Liu XP, Long DY, Yu RH, Kalifa J, et al. Metabolic syndrome and risk of recurrence of atrial fibrillation after catheter ablation. Circ J 2009; 73: 438-443.
9. Mihm MJ, Yu F, Carnes CA, Reiser PJ, McCarthy PM, Van Wagoner DR, et al. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation 2001; 104: 174-180.
10. Heo SH, Lee SH. High levels of serum uric acid are associated with silent brain infarction. J Neurol Sci 2010: 297: 6-10.
11. Kim TH, Lee SS, Yoo JH, Kim SR, Yoo SJ, Song HC, et al. The relationship between the regional abdominal adipose tissue distribution and the serum uric acid levels in people with type 2 diabetes mellitus. Diabetol Metab Syndr 2012; 4: 3.
12. Baker JF, Krishnan E, Chen L, Schumacher HR. Serum uric acid and cardiovascular disease: recent developments, and where do they leave us? Am J Med 2005; 118: 816-826.
13. Korantzopoulos P, Kolettis TM, Galaris D, Goudevenos JA. The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation. Int J Cardiol 2007; 115: 135-143.
14. Diez J. Review of the molecular pharmacology of losartan and its possible relevance to stroke prevention in patients with hypertension. Clin Ther 2006; 28: 832-848.
15. Letsas KP, Siklody CH, Korantzopoulos P, Weber R, Burkle G, Mihas CC, et al. The impact of body mass index on the efficacy and safety of catheter ablation of atrial fibrillation. Int J Cardiol 2011; Epub ahead of print.
16. Kim SM, Lee JH, Kim JR, Shin DG, Lee SH, Cho KH. Female patients with atrial fibrillation have increased oxidized and glycated lipoprotein properties and lower apolipoprotein A-I expression in HDL. Int J Mol Med 2011; 27: 841-849.
17. Letsas KP, Korantzopoulos P, Filippatos GS, Mihas CC, Markou V, Gavrielatos G, et al. Uric acid elevation in atrial fibrillation. Hellenic J Cardiol 2010; 51: 209-213.
18. Yamashita T, Sekiguchi A, Iwasaki YK, Date T, Sagara K, Tanabe H, et al. Recruitment of immune cells across atrial endocardium in human atrial fibrillation. Circ J 2010; 74: 262-270.
19. Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 2003; 41: 1183-1190.
20. Ehrlich JR, Kaluzny M, Baumann S, Lehmann R, Hohnloser SH. Biomarkers of structural remodelling and endothelial dysfunction for prediction of cardiovascular events or death in patients with atrial fibrillation. Clin Res Cardiol 2011; 100: 1029-1036.
21. Van Hoorenbeeck K, Franckx H, Debode P, Aerts P, Wouters K, Ramet J, et al. Weight loss and sleep-disordered breathing in childhood obesity: effects on inflammation and uric acid. Obesity (Silver Spring) 2012; 20: 172-177.
22. Sun CC, Luo FF, Wei L, Lei M, Li GF, Liu ZL, et al. Association of serum uric acid levels with the progression of Parkinson's disease in Chinese patients. Chin Med J 2012; 125: 583-587.
23. Glantzounis GK, Tsimoyiannis EC, Kappas AM, Galaris DA. Uric acid and oxidative stress. Curr Pharm Des 2005; 11: 4145-4151.
24. Dudley SC Jr, Hoch NE, McCann LA, Honeycutt C, Diamandopoulos L, Fukai T, et al. Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage: role of the NADPH and xanthine oxidases. Circulation 2005; 112: 1266-1273.
25. Ben-Dov IZ, Kark JD. Serum uric acid is a GFR-independent long-term predictor of acute and chronic renal insufficiency: The jerusalem lipid research clinic cohort study. Nephrol Dial Transplant 2011; 26: 2558-2566.
26. Chao TF, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, et al. Associations between renal function, atrial substrate properties and outcome of catheter ablation in patients with paroxysmal atrial fibrillation. Circ J 2011; 75: 2326-2332.
27. Tokuda M, Yamane T, Matsuo S, Ito K, Narui R, Hioki M, et al. Relationship between renal function and the risk of recurrent atrial fibrillation following catheter ablation. Heart 2011; 97: 137-142.
28. Shimano M, Shibata R, Inden Y, Yoshida N, Uchikawa T, Tsuji Y, et al. Reactive oxidative metabolites are associated with atrial conduction disturbance in patients with atrial fibrillation. Heart Rhythm 2009; 6: 935-940.
29. Leftheriotis DI, Fountoulaki KT, Flevari PG, Parissis JT, Panou FK, Andreadou IT, et al. The predictive value of inflammatory and oxidative markers following the successful cardioversion of persistent lone atrial fibrillation. Int J Cardiol 2009; 135: 361-369.
30. Zhao QY, Yu SB, Huang H, Cui HY, Qin M, Huang T, et al. Serum uric acid levels correlate with atrial fibrillation in patients with chronic systolic heart failure. Chin Med J 2012; 125: 1708-1712.